Valuation (33%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 30.09 | 35.31 |
| PEG Ratio (TTM) | -3.11 | 12.22 |
| P/S Ratio (TTM) | 3.63 | 14.57 |
| P/B Ratio (TTM) | 4.55 | 18.17 |
| P/FCF Ratio (TTM) | 27.69 | 42.17 |
| Price to 5YR AVG Earnings Ratio | N/A | 34.96 |
| Price to 5YR AVG FCF Ratio | N/A | 60.47 |
Profitability (35%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.46% | 12.53% |
| ROE (TTM) | 15.38% | -3.83% |
| Net Profit Margin (TTM) | 11.25% | 25.54% |
| ROIC 5YR AVG | N/A | 5.37% |
Growth (38%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 15.21% | -2,896.33% | N/A |
| Revenue | 3.79% | 22.63% | N/A |
| Net Income | 14.50% | -1,396.73% | N/A |
| Cash Flow | -3.22% | 44.35% | N/A |
Health (33%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.09 | 1.39 |
| Quick Ratio (TTM) | 1.09 | 1.37 |
| D/E Ratio (TTM) | 0.06 | 1.18 |
| Interest Coverage (TTM) | 1.40 | 33.69 |
| Piotroski F-Score | 6 | 6 |
| Altman Z-Score | 0.38 | 9.05 |
| LTL to 5YR AVG FCF | N/A | 5.30 |
| Shares Outstanding Growth 5YR AVG | N/A | 0.37% |